209 related articles for article (PubMed ID: 21975290)
41. Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics.
Verna EC; Hwang C; Stevens PD; Rotterdam H; Stavropoulos SN; Sy CD; Prince MA; Chung WK; Fine RL; Chabot JA; Frucht H
Clin Cancer Res; 2010 Oct; 16(20):5028-37. PubMed ID: 20876795
[TBL] [Abstract][Full Text] [Related]
42. Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients.
Hu C; Hart SN; Bamlet WR; Moore RM; Nandakumar K; Eckloff BW; Lee YK; Petersen GM; McWilliams RR; Couch FJ
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):207-11. PubMed ID: 26483394
[TBL] [Abstract][Full Text] [Related]
43. BRCA2 germline mutations in familial pancreatic carcinoma.
Hahn SA; Greenhalf B; Ellis I; Sina-Frey M; Rieder H; Korte B; Gerdes B; Kress R; Ziegler A; Raeburn JA; Campra D; Grützmann R; Rehder H; Rothmund M; Schmiegel W; Neoptolemos JP; Bartsch DK
J Natl Cancer Inst; 2003 Feb; 95(3):214-21. PubMed ID: 12569143
[TBL] [Abstract][Full Text] [Related]
44. Increased incidence of extrapancreatic neoplasms in patients with IPMN: Fact or fiction? A critical systematic review.
Pugliese L; Keskin M; Maisonneuve P; D'Haese JG; Marchegiani G; Wenzel P; Del Chiaro M; Ceyhan GO
Pancreatology; 2015; 15(3):209-16. PubMed ID: 25841270
[TBL] [Abstract][Full Text] [Related]
45. Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer.
Sheel ARG; Harrison S; Sarantitis I; Nicholson JA; Hanna T; Grocock C; Raraty M; Ramesh J; Farooq A; Costello E; Jackson R; Chapman M; Smith A; Carter R; Mckay C; Hamady Z; Aithal GP; Mountford R; Ghaneh P; Hammel P; Lerch MM; Halloran C; Pereira SP; Greenhalf W
Am J Gastroenterol; 2019 Jan; 114(1):155-164. PubMed ID: 30353057
[TBL] [Abstract][Full Text] [Related]
46. Differential expression of GNAS and KRAS mutations in pancreatic cysts.
Lee LS; Doyle LA; Houghton J; Sah S; Bellizzi AM; Szafranska-Schwarzbach AE; Conner JR; Kadiyala V; Suleiman SL; Banks PA; Andruss BF; Conwell DL
JOP; 2014 Nov; 15(6):581-6. PubMed ID: 25435574
[TBL] [Abstract][Full Text] [Related]
47. Prevalence of pancreaticobiliary cancers in Irish families with pathogenic BRCA1 and BRCA2 variants.
Power R; Leavy C; Nolan C; White N; Clarke R; Cadoo KA; Gallagher DJ; Lowery MA
Fam Cancer; 2021 Apr; 20(2):97-101. PubMed ID: 32918181
[TBL] [Abstract][Full Text] [Related]
48. Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic.
Borecka M; Zemankova P; Vocka M; Soucek P; Soukupova J; Kleiblova P; Sevcik J; Kleibl Z; Janatova M
Cancer Genet; 2016 May; 209(5):199-204. PubMed ID: 27106063
[TBL] [Abstract][Full Text] [Related]
49. Surveillance Outcome and Genetic Findings in Individuals at High Risk of Pancreatic Cancer.
Rosner G; Scapa E; Ziv T; Gluck N; Ben-Yehoyada M
Clin Transl Gastroenterol; 2024 Feb; 15(2):e00668. PubMed ID: 38147532
[TBL] [Abstract][Full Text] [Related]
50. Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in
Saldia A; Olson SH; Nunes P; Liang X; Samson ML; Salo-Mullen E; Marcell V; Stadler ZK; Allen PJ; Offit K; Kurtz RC
Cancer Prev Res (Phila); 2019 Sep; 12(9):599-608. PubMed ID: 31337648
[TBL] [Abstract][Full Text] [Related]
51. Autoimmune pancreatitis type-1 associated with intraduct papillary mucinous neoplasm: report of two cases.
Vaquero EC; Salcedo MT; Cuatrecasas M; De León H; Merino X; Navarro S; Ginès A; Abu-Suboh M; Balsells J; Fernández-Cruz L; Molero X
Pancreatology; 2014; 14(4):316-8. PubMed ID: 25062884
[TBL] [Abstract][Full Text] [Related]
52. Intraductal papillary mucinous neoplasm of the ileal heterotopic pancreas in a patient with hereditary non-polyposis colorectal cancer: A case report.
Lee SH; Kim WY; Hwang DY; Han HS
World J Gastroenterol; 2015 Jul; 21(25):7916-20. PubMed ID: 26167093
[TBL] [Abstract][Full Text] [Related]
53. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.
Poley JW; Kluijt I; Gouma DJ; Harinck F; Wagner A; Aalfs C; van Eijck CH; Cats A; Kuipers EJ; Nio Y; Fockens P; Bruno MJ
Am J Gastroenterol; 2009 Sep; 104(9):2175-81. PubMed ID: 19491823
[TBL] [Abstract][Full Text] [Related]
54. Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression.
Gentiluomo M; Corradi C; Arcidiacono PG; Crippa S; Falconi M; Belfiori G; Farinella R; Apadula L; Lauri G; Bina N; Rizzato C; Canzian F; Morelli L; Capurso G; Campa D
Front Oncol; 2023; 13():1172606. PubMed ID: 37346070
[TBL] [Abstract][Full Text] [Related]
55. The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants.
Laish I; Schechter M; Dancour A; Lieberman S; Levi Z; Goldberg Y; Kedar I; Hasnis E; Half E; Levi GR; Katz L; Vainer ED; Genzel D; Aharoni M; Chen-Shtoyerman R; Abu-Freha N; Raitses-Gurevich M; Golan T; Bernstein-Molho R; Ben Yehoyada M; Gluck N; Rosner G
Cancer; 2024 Jan; 130(2):256-266. PubMed ID: 37861363
[TBL] [Abstract][Full Text] [Related]
56. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.
Aslanian HR; Lee JH; Canto MI
Gastroenterology; 2020 Jul; 159(1):358-362. PubMed ID: 32416142
[TBL] [Abstract][Full Text] [Related]
57. German national case collection of familial pancreatic cancer - clinical-genetic analysis of the first 21 families.
Rieder H; Sina-Frey M; Ziegler A; Hahn SA; Przypadlo E; Kress R; Gerdes B; Colombo Benkmann M; Eberl T; Grützmann R; Lörken M; Schmidt J; Bartsch DK
Onkologie; 2002 Jun; 25(3):262-6. PubMed ID: 12119461
[TBL] [Abstract][Full Text] [Related]
58. Hereditary pancreatic cancer.
Lynch HT; Brand RE; Deters CA; Shaw TG; Lynch JF
Pancreatology; 2001; 1(5):466-71. PubMed ID: 12120226
[TBL] [Abstract][Full Text] [Related]
59. Single Nucleotide Polymorphisms within the 8Q24 Region are Not Associated with the Risk of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Panic N; Larghi A; Amore R; Pastorino R; Bulajic M; Costamagna G; Boccia S
J Gastrointestin Liver Dis; 2016 Sep; 25(3):311-5. PubMed ID: 27689194
[TBL] [Abstract][Full Text] [Related]
60. Absence of germline BRCA1 mutations in familial pancreatic cancer patients.
Axilbund JE; Argani P; Kamiyama M; Palmisano E; Raben M; Borges M; Brune KA; Goggins M; Hruban RH; Klein AP
Cancer Biol Ther; 2009 Jan; 8(2):131-5. PubMed ID: 19029836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
